E3P-24176-02645
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 528 / IA
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Dose 1 — Pfizer-BioNTech
-
2021-03-20
Registered in v-safe
-
2021-03-20
Dose 2 — Pfizer-BioNTech
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-04-04
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-06-19
- 2021-09-20
-
2022-03-20
Survey response — 12 months, dose 2MedDRA: Hand-foot-and-mouth disease, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Hand foot mouth Bad coldMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-20 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 11 — 12 months, dose 2
Symptoms: Hand foot mouth Bad cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release